Bristol-Myers Squibb CompanyNYSE: BMY

Bristol Myers Squibb Deepens Commitment to Healthcare Professionals Through Champions in Care Movement

· Issued by Bristol-Myers Squibb Company via Business Wire

Summary by 6ix AI

Bristol Myers Squibb, a maker of medicines, expanded Champions in Care, its program honoring healthcare professionals first launched in 2025, and said it will award $1 million in grants to nonprofit organizations supporting medically underserved communities across the United States.

Key details

  • Grant applicants will be identified through an anonymous nomination process, and Bristol Myers Squibb welcomes nominations from healthcare professionals.
  • The deadline for nominations is November 30, 2026.
  • Bristol Myers Squibb plans additional social, digital and live medical meeting activities under Champions in Care through the rest of the year.

What’s still pending

  • Nomination does not guarantee funding; nominated organizations may be invited to apply and will go through a separate review and selection process before any awards are made.

6ix AI wrote this summary from the release below and checked it against the release.

Second-Year Champions in Care Campaign Introduces $1 Million Community Grant Program for Medically Underserved Communities

PRINCETON, N.J., October 01, 2026--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced the expansion of Champions in Care, the company's initiative honoring healthcare professionals (HCPs), first launched in 2025. Now in its second year, the campaign builds on its inaugural effort that celebrated HCPs across therapeutic areas through digital, social and live engagement. This year's expansion introduces new opportunities for HCPs to extend their impact beyond patient care and into the communities they serve.

As part of this year's campaign, Bristol Myers Squibb will award $1 million in grants to nonprofit organizations supporting medically underserved communities across the United States. Grant applicants will be identified through an anonymous nomination process designed to recognize organizations helping to close gaps in care. We welcome nominations from HCPs, who we know are uniquely positioned to understand their communities' most pressing needs and the barriers patients face in accessing care.

"Last year, we launched Champions in Care to recognize the extraordinary impact HCPs have on patients, families and communities," said Adam Lenkowsky, executive vice president, chief commercialization officer, Bristol Myers Squibb. "This year, we're building on that foundation by giving HCPs the opportunity to acknowledge organizations that support the medically underserved communities they serve."

More information about the nomination process and criteria can be found here. The deadline for nominations is November 30, 2026. Nomination does not guarantee funding; nominated organizations may be invited to apply for a grant and will be considered through a separate review and selection process before any awards are made.

Throughout the remainder of the year, Bristol Myers Squibb will bring Champions in Care to life through additional social, digital and live medical meeting activations that celebrate HCPs and highlight their contributions to patients and communities around the world.

For more information about Champions in Care and how Bristol Myers Squibb is recognizing the HCPs that care for all of us, visit www.ChampionsInCare.com.

About Bristol Myers Squibb: Transforming Patients' Lives Through Science
At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what's possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com or follow us on LinkedIn, X, YouTube, Facebook and Instagram.

corporatefinancial-news

View source version on businesswire.com: https://www.businesswire.com/news/home/20260930815023/en/

Contacts

Bristol Myers Squibb

Media Inquiries:
[email protected]

Investors:
[email protected]

View original source (Business Wire)Bristol-Myers Squibb Company on 6ix

Earlier from Bristol-Myers Squibb

Later from Bristol-Myers Squibb

All Bristol-Myers Squibb news releases